KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xenon Pharmaceuticals (XENE) Interest Expenses (2018 - 2020)

Xenon Pharmaceuticals (XENE) has disclosed Interest Expenses for 4 consecutive years, with $154000.0 as the latest value for Q2 2020.

  • Quarterly Interest Expenses fell 57.81% to $154000.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $154000.0 through Mar 2021, down 89.05% year-over-year, with the annual reading at $484000.0 for FY2020, 66.25% down from the prior year.
  • Interest Expenses for Q2 2020 was $154000.0 at Xenon Pharmaceuticals, down from $330000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $678000.0 in Q3 2018, with the low at $154000.0 in Q2 2020.
  • Average Interest Expenses over 3 years is $328333.3, with a median of $348000.0 recorded in 2019.
  • The sharpest move saw Interest Expenses soared 125.16% in 2019, then crashed 57.81% in 2020.
  • Over 3 years, Interest Expenses stood at $678000.0 in 2018, then crashed by 48.67% to $348000.0 in 2019, then tumbled by 55.75% to $154000.0 in 2020.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $154000.0, $330000.0, and $348000.0 for Q2 2020, Q1 2020, and Q4 2019 respectively.